These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8425646)
1. Adverse effects of leuprolide acetate depot treatment. Friedman AJ; Juneau-Norcross M; Rein MS Fertil Steril; 1993 Feb; 59(2):448-50. PubMed ID: 8425646 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025 [TBL] [Abstract][Full Text] [Related]
3. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206 [TBL] [Abstract][Full Text] [Related]
4. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. Sherwin BB; Tulandi T J Clin Endocrinol Metab; 1996 Jul; 81(7):2545-9. PubMed ID: 8675575 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512 [TBL] [Abstract][Full Text] [Related]
6. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group. Agarwal SK; Hamrang C; Henzl MR; Judd HL J Reprod Med; 1997 Jul; 42(7):413-23. PubMed ID: 9252932 [TBL] [Abstract][Full Text] [Related]
7. Leuprolide acetate depot decreases the number of nucleolar organizer regions in uterine leiomyomata. Barbieri RL; Dilena M; Chumas J; Rein MS; Friedman AJ Fertil Steril; 1993 Sep; 60(3):569-70. PubMed ID: 8375543 [TBL] [Abstract][Full Text] [Related]
8. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510 [TBL] [Abstract][Full Text] [Related]
9. [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis]. D'Anna R; Palmara V; Lo Re C; Scilipoti A; Leonardi I Minerva Ginecol; 1994 Jun; 46(6):343-6. PubMed ID: 7936386 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group]. Stolz W; Pfützenreuter N Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825 [TBL] [Abstract][Full Text] [Related]
11. Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women. Rittmaster RS; Arab DM; Lehman L Fertil Steril; 1996 May; 65(5):912-5. PubMed ID: 8612847 [TBL] [Abstract][Full Text] [Related]
12. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis]. Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer. Mostafa NM; Chwalisz K; Larsen L; Mattia-Goldberg C; Spitz A; Pradhan RS Clin Pharmacol Drug Dev; 2014 Jul; 3(4):270-5. PubMed ID: 27128832 [TBL] [Abstract][Full Text] [Related]
14. Effects of two different doses of leuprolide acetate depot on uterine cavity area in patients with uterine leiomyomata. Watanabe Y; Nakamura G Fertil Steril; 1995 Mar; 63(3):487-90. PubMed ID: 7851574 [TBL] [Abstract][Full Text] [Related]
15. Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot. Dumesic DA; Matteri RL Int J Fertil Menopausal Stud; 1993; 38(3):139-46. PubMed ID: 8348161 [TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri. Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148 [TBL] [Abstract][Full Text] [Related]
17. Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study. Perino A; Chianchiano N; Petronio M; Cittadini E Fertil Steril; 1993 Mar; 59(3):507-10. PubMed ID: 8458448 [TBL] [Abstract][Full Text] [Related]
18. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638 [TBL] [Abstract][Full Text] [Related]
19. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137 [TBL] [Abstract][Full Text] [Related]
20. Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas. Friedman AJ Hum Reprod; 1993 Apr; 8(4):540-2. PubMed ID: 8501181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]